Medication for Fibroid Symptom Management
Medication can help manage the symptoms of uterine fibroids, particularly heavy menstrual bleeding and pain. However, medications do not remove fibroids and symptoms typically return when treatment is stopped.
GnRH Agonists
Gonadotropin-releasing hormone (GnRH) agonists, such as goserelin (Zoladex) and leuprorelin (Prostap), work by suppressing the production of oestrogen and progesterone, effectively creating a temporary menopausal state. This can cause fibroids to shrink by up to 50% and may significantly reduce heavy menstrual bleeding.
GnRH agonists are typically administered as monthly injections and are generally limited to a course of 3-6 months. Longer use is restricted due to the risk of reduced bone mineral density (osteoporosis) and other menopausal side effects such as hot flushes, night sweats, and mood changes.
These medications are sometimes used as a pre-treatment before surgery or UFE to reduce fibroid size, control bleeding, and improve anaemia. Fibroids usually regrow to their original size within a few months of stopping treatment.
GnRH Antagonists
A newer class of oral medications, GnRH antagonists such as relugolix (available in the UK as part of the combination product Ryeqo) offer an alternative approach to hormonal management of fibroids. These medications work by directly blocking GnRH receptors, rapidly reducing oestrogen levels to a controlled degree.
Ryeqo combines relugolix with low-dose oestrogen and progesterone (add-back therapy) to minimise menopausal side effects and protect bone density. This allows it to be used for longer periods than traditional GnRH agonists. Clinical trials have shown that Ryeqo significantly reduces heavy menstrual bleeding in women with fibroids.
As an oral tablet taken once daily, GnRH antagonists offer the convenience of home-based treatment without injections. However, like all medications for fibroids, symptoms are expected to return when the medication is stopped.
Tranexamic Acid
Tranexamic acid is a non-hormonal medication that works by stabilising blood clots, thereby reducing heavy menstrual bleeding. It is taken as a tablet during the days of heaviest bleeding and can reduce menstrual blood loss by approximately 40-50%.
Tranexamic acid does not affect fibroid size or hormone levels and is well tolerated by most women. Common side effects are mild and may include nausea and digestive discomfort. It is available on prescription and can be used alongside other treatments.
This medication is a practical option for women who wish to manage heavy bleeding without hormonal treatment, or as a temporary measure while considering other options. It is particularly useful for women who cannot take hormonal medications due to contraindications.
Hormonal Contraceptives
Hormonal contraceptives, including the combined oral contraceptive pill, the progesterone-only pill, and the levonorgestrel intrauterine system (Mirena coil), can help manage symptoms of heavy menstrual bleeding associated with fibroids.
The Mirena coil is often particularly effective for reducing heavy periods, as it delivers progesterone directly to the uterine lining. It can be used for up to 5 years and may be suitable for women with smaller fibroids that do not distort the uterine cavity.
Hormonal contraceptives do not shrink fibroids and may not be effective if fibroids are large or if they distort the shape of the uterine cavity (which may make insertion of a Mirena coil difficult or ineffective). Your gynaecologist will advise whether hormonal contraception is a suitable option for your situation.
Anti-Inflammatory Medications
Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and mefenamic acid can help manage pain and cramping associated with fibroids. NSAIDs may also modestly reduce menstrual blood loss by inhibiting prostaglandin production.
These medications are available over the counter or on prescription and are generally taken during the menstrual period. They are most effective when started a day or two before the expected onset of pain or heavy bleeding. NSAIDs do not affect fibroid size.
Limitations of Medical Management
While medication plays an important role in symptom management, it is important to understand its limitations. No currently available medication permanently removes fibroids or prevents their growth. Symptoms typically return when medication is discontinued.
Some medications, particularly GnRH agonists, have significant side effects that limit their long-term use. Others, such as tranexamic acid and NSAIDs, address symptoms without affecting the underlying cause. For many women, medication provides temporary relief but is not a definitive solution.
Medical management may be most appropriate as a short-term or bridging strategy — for example, to control symptoms while awaiting a procedure, to reduce fibroid size before surgery, or to manage symptoms in women approaching the menopause (when fibroids naturally tend to shrink).
When to Consider Other Treatments
If medication is not adequately controlling your symptoms, if you are experiencing troublesome side effects, or if you prefer a more definitive treatment, it may be time to consider other options. Minimally invasive treatments such as Uterine Fibroid Embolisation (UFE) can provide long-lasting symptom relief with a short recovery period.
A consultation with our specialist team can help you understand all available options and determine the most appropriate treatment for your individual circumstances. We will review your medical history, current medication, and imaging to provide personalised advice.
For a comprehensive comparison of all fibroid treatments, please visit our treatment options overview.
Frequently Asked Questions
References
- NICE Guideline [NG88] — Heavy menstrual bleeding: assessment and management. National Institute for Health and Care Excellence.
- Al-Hendy A, et al. Relugolix combination therapy for treatment of uterine fibroids (LIBERTY 1 and LIBERTY 2). New England Journal of Medicine, 2021.
- Lethaby A, Farquhar C, Cooke I. Antifibrinolytics for heavy menstrual bleeding. Cochrane Database of Systematic Reviews.
- Royal College of Obstetricians and Gynaecologists. Clinical recommendations on the use of uterine artery embolisation (UAE) in the management of fibroids. RCOG, 3rd edition.
Explore All Treatment Options
Book a consultation to discuss the best approach for managing your fibroids
Or call us: 01305 608250